Phase I Clinical Trial of ManNAc in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)

Conditions:   Hereditary Inclusion Body Myopathy (HIBM);   GNE MyopathyIntervention:   Drug: ManNAcSponsors:   National Human Genome Research Institute (NHGRI);   National Center for Advancing Translational Science (NCATS);   Therapeutics for Rare and Neglected Diseases (TRND)Completed - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials